Placebo-controlled trial of vaccination with hepatitis B virus surface antigen in hepatitis B virus transgenic mice

This publication has 11 references indexed in Scilit:

• Upregulation of MHC class II antigen on dendritic cells from hepatitis B virus transgenic mice by interferon‐γ: abrogation of immune response defect to a T‐cell‐dependent antigen
  Immunology, 1996
• Hepatitis B vaccine and anti-HBs complex as approach for vaccine therapy
  The Lancet, 1995
• Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.
  Journal of Clinical Investigation, 1995
• Specific vaccine therapy in chronic hepatitis B infection
  The Lancet, 1994
• Interferon in the management of chronic hepatitis B
  Digestive Diseases and Sciences, 1993
• Induction of anti‐hepatitis B surface antigen (HBsAg) antibodies in HBsAg producing transgenic mice: A possible way of circumventing “nonresponse” to HBsAg
  Journal of Medical Virology, 1993
• Immunology and the liver
  Hepatology, 1991
• The cellular basis for lack of antibody response to hepatitis B vaccine in humans.
  The Journal of Experimental Medicine, 1991
• Expression and replication of hepatitis B virus genome in transgenic mice.
  Proceedings of the National Academy of Sciences, 1989
• Chronic type B hepatitis and the “healthy” Hbsag carrier state
  Hepatology, 1987